HTEC – Robo Global® Healthcare Technology and Innovation ETF
Robo Global® Healthcare Technology and Innovation ETF (HTEC) is a Health ETF, issued by Robo Global, $55.9M in assets, 0.68% expense ratio.
Returns as of Oct 23, 2026: 1 week +3.9%, 1 year +25.1%.
Focuses on healthcare technology innovation companies. Invests 80% in index securities or depositary receipts, targeting firms with growth potential in this sector.
Top holdings
- GH – Guardant Health Inc, 2.1%
- TMO – Thermo Fisher Scientific Inc, 2.1%
- MRNA – Moderna Inc, 2.1%
- PEN – Penumbra Inc, 2.0%
- ADPT – Adaptive Biotechnologies Corp, 2.0%
- ARWR – Arrowhead Pharmaceuticals Inc, 2.0%
- SHL – Siemens Healthineers AG, 2.0%
- ERF – Eurofins Scientific SE, 2.0%
- TWST – Twist Bioscience Corp, 2.0%
- ILMN – Illumina Inc, 1.9%
- SYK – Stryker Corporation, 1.9%
- PHIA – Koninklijke Philips NV, 1.9%
- VRTX – Vertex Pharmaceuticals Inc, 1.8%
- IQV – IQVIA Holdings Inc, 1.8%
- NVCR – Novocure Ltd, 1.8%
- NTRA – Natera Inc, 1.8%
- NOVT – Novanta Inc, 1.8%
- REGN – Regeneron Pharmaceuticals Inc, 1.8%
- LONN – Lonza Group AG, 1.8%
- CRL – Charles River Laboratories, 1.8%
- AXGN – Axogen Inc, 1.8%
- 6618 – Jd Health International Inc, 1.8%
- ISRG – Intuitive Surgical Inc, 1.8%
- MEDP – Medpace Holdings Inc, 1.8%
- LIVN – LivaNova PLC, 1.8%